Re: Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities.
Bradley
Elspeth A
EA
Lunsky
Yona
Y
Berg
Joseph M
JM
Brooks-Hill
Robin W
RW
O'Leary
Donal A
DA
Harman
Karen E
KE
Korossy
Marika
M
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002170:Canada; D002658:Developmental Disabilities / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy* / Q000523:psychology; D008134:Long-Term Care; D008297:Male; D016896:Treatment Outcome
D014150:Antipsychotic Agents